Navigation Links
ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary.

EDINA, Minn., Oct. 28, 2011 /PRNewswire/ -- ARKRAY USA, Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and 01 are now listed on the Department of Defense (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee (P&T) selected both the GLUCOCARD® Vital and the GLUCOCARD® 01 Blood Glucose Meters as the first and second most cost effective blood glucose meters in all points of service as noted by the Uniform Formulary Beneficiary Advisory Panel (BAP) earlier this year.

Both GLUCOCARD Vital and GLUCOCARD 01 meter systems feature advanced auto coding technology and require only a tiny sample size at a cost that is less than other blood glucose meter systems on the Uniform Formulary including the current blood glucose meter offered on the Basic Core Formulary.  

"We're excited that ARKRAY has two meters on the Department of Defense Uniform Formulary," said Jonathan Chapman, President of ARKRAY. "Our GLUCOCARD meter systems offer high performance standards.  To be recognized by the DoD for having the most cost-effective blood glucose meters is an honor."

GLUCOCARD meters work with ARK Care™, a Real-Time Diabetes Data Management System.  This unique, patient focused, online software for diabetes management allows patients, healthcare providers and care givers to capture data, see results, and manage ones diabetes. Every GLUCOCARD meter is backed by our GLUCOCARD YouChoose® Wellness and Support Program. Exclusively for GLUCOCARD patients, the program provides free education and support materials, recipes, meal planners, ongoing support, and more.  

ARKRAY will be demonstrating their GLUCOCARD Blood Glucose Meters at the Joint Forces Pharmacy Seminar (JFPS) in Dallas, TX next week.  "Exhibiting at the largest annual event for the military pharmacy community is the perfect opportunity to show pharmacists and technicians first hand how our products perform for their patients with diabetes," said Robert Wernsman, Vice President of Consumer Healthcare Division.


ARKRAY has been a pioneer for over 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self testing systems. ARKRAY invests heavily in R&D and has a strong commitment to high-quality products. ARKRAY is the company that developed the world's commercially successful portable blood glucose analyzer in the early 1970s and the world's first A1C analyzer in 1982.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vitala™ Pouchless Continence Control Device Shown to be Safe and Effective for up to 12 Hours in Phase 3 Clinical Trial
2. BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®
3. SAIC Completes Acquisition of Vitalize Consulting Solutions, Inc.
4. ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
5. Recall of Infant and Neonatal-Sized FilterLine H Set and VitaLine H Set Sampling Lines
6. AT&T Connected Vitality GlowCaps Wins 2011 Global Mobile Award
7. Vitalitec Acquires ENCLOSE II Anastomosis Assist Device
8. Dr. F. Stockmans, One of the Earliest Proponents of Materialises Surgicase(R) Orthopaedics, States the Case for its Vital Role in the Treatment of Distal Radius Malunions at ASSH 2010
9. FUJIFILM Revitalizes Images of Health Breast Cancer Awareness Initiative
10. Honoring Those Who Collect Blood, Medicines Most Vital Natural Resource
11. Detailed Cholesterol Test Provides Vital Clues for Women in Search of PCOS Answers
Post Your Comments:
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):